Showing results (161-170 of 178) with videos related to
Sort By:
Pageof 18
Critical Care Nurse|April 1, 2025
Tele-Intensive Care Unit Collaboration to Decrease Pressure Injuries: A Quality Improvement ProjectKelly Small, Jason White, Christopher Palmer, et al.International Journal of Language & Communication Disorders|November 19, 2016
Effectiveness of 1:1 speech and language therapy for older children with (developmental) language disorderSusan H Ebbels, Lisa Wright, Sally Brockbank, et al.Bioorganic & Medicinal Chemistry Letters|October 11, 2005
3-(5-Chloro-2,4-dihydroxyphenyl)-pyrazole-4-carboxamides as inhibitors of the Hsp90 molecular chaperonePaul A Brough, Xavier Barril, Mandy Beswick, et al.Bioorganic & Medicinal Chemistry Letters|December 31, 2003
Adenine derived inhibitors of the molecular chaperone HSP90-SAR explained through multiple X-ray structuresBrian Dymock, Xavier Barril, Mandy Beswick, et al.The Journal of Experimental Medicine|August 22, 2012
IL-1R-MyD88 signaling in keratinocyte transformation and carcinogenesisChristophe Cataisson, Rosalba Salcedo, Shakeeb Hakim, et al.Clinical Gerontologist|March 29, 2024
Telehealth Cognitive Behavior Therapy to Reduce Anxiety in People Living with Cognitive Impairment: A Randomized Feasibility Pilot StudyGabriela Pacas Fronza, Leander K Mitchell, Nancy A Pachana, et al.Carcinogenesis|March 6, 2012
CLIC4 is a tumor suppressor for cutaneous squamous cell cancerK Stephen Suh, Mariam Malik, Anjali Shukla, et al.Trials|June 20, 2023
A single-blind, parallel-group randomised trial of a Technology-assisted and remotely delivered Cognitive Behavioural Therapy intervention (Tech-CBT) versus usual care to reduce anxiety in people with mild cognitive impairment and dementia: study protocol for a randomised trialNadeeka Dissanayaka, Deborah Brooks, Peter Worthy, et al.Bioorganic & Medicinal Chemistry Letters|February 17, 2006
4-Amino derivatives of the Hsp90 inhibitor CCT018159Xavier Barril, Mandy C Beswick, Adam Collier, et al.Journal of Medicinal Chemistry|June 25, 2005
Novel, potent small-molecule inhibitors of the molecular chaperone Hsp90 discovered through structure-based designBrian W Dymock, Xavier Barril, Paul A Brough, et al.Pageof 18